• Impact of a Collaborative Pharmaceutical Care Service Among Patients With Diabetes in an Ambulatory Care Setting in Qatar: A Multiple Time Series Study

    Sep 1, 2019, 00:00

  • External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

    Sep 1, 2019, 00:00

  • Impact of Disparities in Reimbursement Rules Between Public and Private Sectors on Accessibility to Care in Moroccan Mandatory Health Insurance: A Cross-Sectional Study

    Sep 1, 2019, 00:00

  • Pseudo-Generics in South Africa: A Price Comparison

    Sep 1, 2019, 00:00

  • The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems

    Sep 1, 2019, 00:00

  • Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    Sep 1, 2019, 00:00

  • Copyright/Subscription

    Jun 11, 2019, 09:02

  • Assessing Diabetes Distress Among Type 2 Diabetes Mellitus in Malaysia Using the Problem Areas in Diabetes Scale

    May 1, 2019, 00:00

  • Comparison of Equity Preferences for Life Expectancy Gains: A Discrete Choice Experiment Among the Japanese and Korean General Public

    May 1, 2019, 00:00

  • Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran

    May 1, 2019, 00:00

  • Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools

    May 1, 2019, 00:00

  • Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?

    May 1, 2019, 00:00

  • Editorial Board

    May 1, 2019, 00:00

  • Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review

    May 1, 2019, 00:00

  • Budget Impact Analysis of Rotavirus Vaccine Adoption in the Childhood Immunization Schedule of Iran

    May 1, 2019, 00:00

  • Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea

    May 1, 2019, 00:00

  • A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

    May 1, 2019, 00:00

  • Retraction notice

    May 1, 2019, 00:00

  • Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India

    May 1, 2019, 00:00

  • From Research to Policy Implementation: Trastuzumab in Early-Stage Breast Cancer Treatment in Thailand

    May 1, 2019, 00:00

  • Health-Related Quality of Life of Pediatric Spinal Surgery Complications

    May 1, 2019, 00:00

  • Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis

    May 1, 2019, 00:00

  • Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran

    May 1, 2019, 00:00

  • Table of Contents

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policies: Singapore

    May 1, 2019, 00:00

  • The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan

    May 1, 2019, 00:00

  • Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach

    May 1, 2019, 00:00

  • Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policy in Malaysia

    May 1, 2019, 00:00

  • A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs

    May 1, 2019, 00:00

  • Economics of Medical Devices in India

    May 1, 2019, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review

    May 1, 2019, 00:00

  • Role of Health Technology Assessment in Drug Policies: Korea

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran

    May 1, 2019, 00:00

  • Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus

    May 1, 2019, 00:00

  • Copyright/Subscription

    Dec 19, 2018, 18:04

  • Copyright/Subscription

    Dec 13, 2018, 10:12

  • Good Practices and Principles in Health Technology Assessment in Latin America

    Dec 1, 2018, 00:00

  • Internal Consistency of the SF-6D as a Health Status Index in the Brazilian Urban Population

    Dec 1, 2018, 00:00

  • End-Stage Renal Disease Models in the Americas- Optimizing Resources to Achieve Better Health Outcomes

    Dec 1, 2018, 00:00

  • Cost-Effective Analysis to Incorporate Non-Drug Interventions to Increase Adherence to Antiretroviral Therapy

    Dec 1, 2018, 00:00

  • Gasto de Bolsillo en Salud y Medicamentos en Chile- Análisis Comparativo de los Periodos 1997, 2007, y 2012

    Dec 1, 2018, 00:00

  • Activity-Based Costing and Time-Driven Activity-Based Costing for Assessing the Costs of Cancer Prevention, Diagnosis, and Treatment- A Systematic Review of the Literature

    Dec 1, 2018, 00:00

  • What Is a Value Management Office? An Implementation Experience in Latin America

    Dec 1, 2018, 00:00

  • ERM for Health Care Organizations: An Economic Enterprise Risk Management Innovation Program (E2RMhealth care)

    Dec 1, 2018, 00:00

  • Ingredientes Farmacéuticos Activos Potencialmente Inapropiados en Adultos Mayores- Lista IFAsPIAM- Panel de Consenso Argentino

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of a Home Visit Program for Patients with Heart Failure in Brazil- Evidence from a Randomized Clinical Trial

    Dec 1, 2018, 00:00

  • Social Context and Geographic Space- An Ecological Study about Hospitalizations of Older Persons

    Dec 1, 2018, 00:00

  • Engagement in a Community Physical Activity Program and Its Effects Upon the Health-Related Quality of Life of Elderly People- A Cross-Sectional Study

    Dec 1, 2018, 00:00

  • Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean

    Dec 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia

    Dec 1, 2018, 00:00

  • Table of Contents

    Dec 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia

    Dec 1, 2018, 00:00

  • Cost-Utility Study of PCV13 Versus PPSV23 in Adults in Chile

    Dec 1, 2018, 00:00

  • Análisis de Costo de la Enfermedad, del Tratamiento, las Complicaciones e Intervenciones de la Hipercolesterolemia en México en 2016

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico

    Dec 1, 2018, 00:00

  • Editorial Board

    Dec 1, 2018, 00:00

  • Health Care Cost for Multiple Sclerosis- The Case of a Health Insurer in Colombia

    Dec 1, 2018, 00:00

  • Economic Costs of Chikungunya Virus in Colombia

    Dec 1, 2018, 00:00

  • Value-Based Pricing in Latin America- How Far Away Are We?

    Dec 1, 2018, 00:00

  • Electronic Version of the EQ-5D Quality-of-Life Questionnaire- Adaptation to a Brazilian Population Sample

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia- A Colombian Experience

    Dec 1, 2018, 00:00

  • Drug Utilization Studies in Latin America- A Scoping Review and Survey of Ethical Requirements

    Dec 1, 2018, 00:00

  • Inflammatory Bowel Disease in Latin America- A Systematic Review

    Dec 1, 2018, 00:00

  • Postintroduction Study of Cost-Effectiveness of Pneumococcal Vaccine PCV10 from Public Sector Payer’s Perspective in the State of Santa Catarina, Brazil

    Dec 1, 2018, 00:00

  • Reparación Endovascular para Aneurisma de Aorta- Revisión Panorámica Sobre su Evidencia en el Mundo y su Aplicación en Latinoamérica

    Dec 1, 2018, 00:00

  • Análisis de los Determinantes Socioeconómicos del Gasto de Bolsillo en Medicamentos en Seis Zonas Geográficas de Panamá

    Dec 1, 2018, 00:00

  • Bipolar Disorder Mixed Episodes- A Pragmatic Trial of a Public Health Treatment Effectiveness

    Dec 1, 2018, 00:00

  • Drug-Related Morbidity in Brazil- A Cost-of-Illness Model

    Dec 1, 2018, 00:00

  • Potentially Inappropriate Medications in Elderly Ambulatory Patients- A Comparative Study between a Primary Health Care Center and a Community Pharmacy

    Dec 1, 2018, 00:00

  • Brazilian Analytical Decision Model for Cardiovascular Disease- An Adaptation of the Scottish Cardiovascular Disease Policy Model

    Dec 1, 2018, 00:00

  • Hipoglicemiantes Orais Para Diabetes Mellitus Tipo 2- Comparação de Preços no Brasil e em Outros Sistemas Universais de Saúde

    Dec 1, 2018, 00:00

  • Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union

    Sep 1, 2018, 00:00

  • Editorial Board

    Sep 1, 2018, 00:00

  • Highly Innovative Drug Program in the Czech Republic- Description and Pharmacoeconomic Results—Cost-Effectiveness and Budget Impact Analyses

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1–Infected Treatment-Naive Patients in Russia

    Sep 1, 2018, 00:00

  • The State of Health Technology Assessment in the Ethiopian Health Sector- Learning from Recent Policy Initiatives

    Sep 1, 2018, 00:00

  • Table of Contents

    Sep 1, 2018, 00:00

  • Optimization Approach for Estimating the Required Amount of Pharmaceuticals in the Russian Federation

    Sep 1, 2018, 00:00

  • Managed Entry Agreements for Pharmaceutical Products in Middle East and North African Countries- Payer and Manufacturer Experience and Outlook

    Sep 1, 2018, 00:00

  • Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt- Implications for Developing Countries

    Sep 1, 2018, 00:00

  • Drug Policy in Estonia

    Sep 1, 2018, 00:00

  • Drug Policy in Romania

    Sep 1, 2018, 00:00

  • Treatment Satisfaction Questionnaire for Medication- Validation of the Translated Arabic Version among Patients Undergoing Warfarin Therapy in Saudi Arabia

    Sep 1, 2018, 00:00

  • Smoking Behavior among Jordanians- Physical, Psychological, Social, and Economic Reasons

    Sep 1, 2018, 00:00

  • Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Evaluations of Oral Anticancer Agents- Systematic Review of Characteristics, Methodological Trends, and Reporting Quality

    Sep 1, 2018, 00:00

  • Drug Policy in the Russian Federation

    Sep 1, 2018, 00:00

  • An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets

    Sep 1, 2018, 00:00

  • Drug Policy in Greece

    Sep 1, 2018, 00:00

  • Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD—A Cost-Effectiveness Analysis in the Czech Republic

    Sep 1, 2018, 00:00

  • Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa- The Interface Between Research Evidence, Policy, and Practice

    Sep 1, 2018, 00:00

  • Copyright/Subscription

    Jul 26, 2018, 13:37

  • Excess Hospitalization Expenses Attributable to Type 2 Diabetes Mellitus in Singapore

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Recent Pricing Negotiations on Innovative Medicines Pilot in China- Experiences, Implications, and Suggestions

    May 1, 2018, 00:00

  • Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance

    May 1, 2018, 00:00

  • How Much Does Management of an Asthma-Related Event Cost in a Malaysian Suburban Hospital?

    May 1, 2018, 00:00

  • The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia- A Systematic Review

    May 1, 2018, 00:00

  • Health Technology Assessment and Its Use in Drug Policies in China

    May 1, 2018, 00:00

  • Health-Related Quality of Life of Patients with HPV-Related Cancers in Indonesia

    May 1, 2018, 00:00

  • Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India

    May 1, 2018, 00:00

  • Resource Use and Cost of Treating Human Papillomavirus–Related Lesions in Japanese Women

    May 1, 2018, 00:00

  • New Drug Reimbursement and Pricing Policy in Taiwan

    May 1, 2018, 00:00

  • Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis- A Study from a Tertiary Care Hospital in Thailand

    May 1, 2018, 00:00

  • A Review of Studies of Quality of Life for Chinese-Speaking Patients with Ischemic Heart Disease

    May 1, 2018, 00:00

  • Health Expenditure Growth under Single-Payer Systems- Comparing South Korea and Taiwan

    May 1, 2018, 00:00

  • Table of Contents

    May 1, 2018, 00:00

  • Evaluation of the Long-Term Impact of Improving Care for People with Type 2 Diabetes in China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital

    May 1, 2018, 00:00

  • Health Utility of Pregnant Women Living with HIV/AIDS- Prevention of Mother-to-Child Transmission of HIV (PMTCT) Programs in Yunnan Province- A Cross-Sectional Study

    May 1, 2018, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease

    May 1, 2018, 00:00

  • Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-Being

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00

  • The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia

    May 1, 2018, 00:00

  • A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients

    May 1, 2018, 00:00

  • Cultural Adaptation and Linguistic Validation of the Beliefs about Medicines Questionnaire in Malaysia

    May 1, 2018, 00:00

  • Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia

    Dec 1, 2017, 00:00

  • A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

    Dec 1, 2017, 00:00

  • Value in Health Regional Issues- PubMed Indexing and Our “Coming of Age”

    Dec 1, 2017, 00:00

  • Burden of Culture-Confirmed Pediatric Pneumococcal Pneumonia in Latin America and the Caribbean- A Systematic Review and Meta-Analysis

    Dec 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection- A Short-Term Pharmacoeconomic Evaluation (12 Months)

    Dec 1, 2017, 00:00

  • HTA Implementation in Latin American Countries- Comparison of Current and Preferred Status

    Dec 1, 2017, 00:00

  • Conducting and Disseminating Epidemiological Systematic Reviews in Latin America and the Caribbean- Pitfalls and Lessons Learned

    Dec 1, 2017, 00:00

  • ViHRI 2017 Reviewer Acknowledgement

    Dec 1, 2017, 00:00

  • Costos medicos directos en pacientes con enfermedad pulmonar obstructiva Crónica en Mexico

    Dec 1, 2017, 00:00

  • Copyright page

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia

    Dec 1, 2017, 00:00

  • ToC

    Dec 1, 2017, 00:00

  • Uso de recursos y costos de hospitalizaciones por insufi ciencia card í aca- un estudio retrospective multic é ntrico en Argentina

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital

    Dec 1, 2017, 00:00

  • Single-Use Devices in Argentina- Cost Comparison Analysis of a “Re-Use” versus a “Single-Use” Policy for Trocars, Endocutters, Linear Cutters, and Harmonic Scalpels

    Dec 1, 2017, 00:00

  • Estudio de impacto presupuestal de Daclatasvir asociado a Asunaprevir desde la perspectiva del sistema de salud público chileno

    Dec 1, 2017, 00:00

  • Doctors Adjacent to Private Pharmacies- The New Ambulatory Care Provider for Mexican Health Care Seekers

    Dec 1, 2017, 00:00

  • Impacto del incremento del impuesto a los productos de tabaco sobre la recaudación y los precios en Panamá

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Intracranial Pressure Monitoring in Pediatric Patients with Severe Traumatic Brain Injury- A Simulation Modeling Approach

    Dec 1, 2017, 00:00

  • Evaluación de tecnologías sanitarias para la toma de decisiones y la rendición de cuentas- una urgente reflexión para el sistema de salud chileno

    Dec 1, 2017, 00:00

  • Editorial comment on Health Technology Assessment (HTA)- Good Practices Principles. FIFARMA’s Position on HTA Processes in Latin America- The Devil Is in the Details

    Dec 1, 2017, 00:00

  • Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases- 1998--2015 Period in Turkey

    Sep 1, 2017, 00:00

  • Concept of Combining Cost-Effectiveness Analysis and Budget Impact Analysis in Health Care Decision-Making

    Sep 1, 2017, 00:00

  • Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets

    Sep 1, 2017, 00:00

  • Drug Policy in Bulgaria

    Sep 1, 2017, 00:00

  • Drug Policy in Hungary

    Sep 1, 2017, 00:00

  • Advancing the Visibility, Impact, and Quality Metrics of Value in Health Regional Issues

    Sep 1, 2017, 00:00

  • ToC

    Sep 1, 2017, 00:00

  • Drug Policy in Slovakia

    Sep 1, 2017, 00:00

  • Synthesizing and Appraising the Quality of the Evidence on Factors Associated with Medication Adherence in Diabetes- A Systematic Review of Systematic Reviews

    Sep 1, 2017, 00:00

  • Drug Policy in Latvia

    Sep 1, 2017, 00:00

  • Functional Social Support for Hypertensive Patients in Primary Care Setting in Poland- What Is Expected and What Is Received?

    Sep 1, 2017, 00:00

  • Copyright Page

    Sep 1, 2017, 00:00

  • Drug Policy in the Czech Republic

    Sep 1, 2017, 00:00

  • Drug Policy in Croatia

    Sep 1, 2017, 00:00

  • Drug Policy in Poland

    Sep 1, 2017, 00:00

  • Drug Policies in Central and Eastern European Countries

    Sep 1, 2017, 00:00

  • Cost-Effectiveness Analysis of New HCV Treatments in Egyptian Cirrhotic and Non-Cirrhotic Patients- A Societal Perspective

    Sep 1, 2017, 00:00

  • Battling Tuberculosis beyond antibiotics

    Sep 1, 2017, 00:00

  • Ebola Virus Epidemic in West Africa- Global Health Economic Challenges, Lessons Learned, and Policy Recommendations

    Sep 1, 2017, 00:00

  • Editorial Board

    Sep 1, 2017, 00:00

  • Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients with Painful Bone Metastases- An Iranian Patient’s Perspective Study

    May 1, 2017, 00:00

  • Comparison on Human Resource Requirement between Manual and Automated Dispensing Systems

    May 1, 2017, 00:00

  • Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in Japan

    May 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial- Taiwanese Perspective

    May 1, 2017, 00:00

  • Cost of Osteoporotic Fractures in Singapore

    May 1, 2017, 00:00

  • Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea

    May 1, 2017, 00:00

  • Cost-Benefit Analysis and Assessment of Quality of Care in patients with Hemophilia undergoing treatment at National Rural Health Mission in Maharashtra, India

    May 1, 2017, 00:00

  • Comparative Study on Health-Related Quality of Life of Farmers and Workers

    May 1, 2017, 00:00

  • Healthy China 2030- A Vision for Health Care

    May 1, 2017, 00:00

  • Exploring Product-Specific Attributes of a Community Cardiac Rehabilitation Program in an Asian Urban City

    May 1, 2017, 00:00

  • Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy- Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene?

    May 1, 2017, 00:00

  • Is It Time for Joint Health Technology Assessment in Asia? Opportunities and Challenges

    May 1, 2017, 00:00

  • Table of Contents

    May 1, 2017, 00:00

  • Minimal Clinically Important Differences (MCIDs) of the Thai Version of the Leicester Cough Questionnaire for Subacute and Chronic Cough

    May 1, 2017, 00:00

  • Copyright/Subscription page

    May 1, 2017, 00:00

  • Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital- Evidence from a Cross-Sectional Study

    May 1, 2017, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Pediatric Patients (Aged 3 Months to 19 Years) in the Philippines

    May 1, 2017, 00:00

  • ViHRI Volume 12 Asia 2017 Reviewer Acknowledgement

    May 1, 2017, 00:00

  • The Emerging Role of Patient-Reported Outcomes (PROs) in Clinical Trials- An Indian Perspective

    May 1, 2017, 00:00

  • Translation, Revision, and Validation of the Diabetes Distress Scale for Indonesian Type 2 Diabetic Outpatients with Various Types of Complications

    May 1, 2017, 00:00

  • Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets

    May 1, 2017, 00:00

  • Psychometric Properties of the Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QOL)

    May 1, 2017, 00:00

  • Estimación de la Relación Costo-Efectividad de las Vacunas Neumocócicas Conjugadas Prevenar-13 y Synflorix®, Utilizadas en Los Programas de Vacunación de Población Infantil Mexicana

    Dec 1, 2016, 00:00

  • Análise de Custo-Efetividade do uso do Sistema de Comunicação e Arquivamento de Imagens (PACS) em mamografias digitais

    Dec 1, 2016, 00:00

  • Guide for Authors

    Dec 1, 2016, 00:00

  • 11C Reviewer Acknowledgment

    Dec 1, 2016, 00:00

  • Cardiovascular Disease and Health Care System Impact on Functionality and Productivity in Argentina- A Secondary Analysis

    Dec 1, 2016, 00:00

  • Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016- brief update

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of the Quantification of Enzymatic Activity in Leukocytes in Comparison to Its Nonrealization for a Rare Disease in Latin America- The Case of Mucopolysaccharidosis Type II in Colombia

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia

    Dec 1, 2016, 00:00

  • Interchangeability between Pneumococcal Conjugate Vaccines- A Systematic Review and Meta-Analysis

    Dec 1, 2016, 00:00

  • Toward Explicit Prioritization for the Caribbean- An EQ-5D Value Set for Trinidad and Tobago

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a Care Program for HIV/AIDS Patients Affiliated with a Health Insurer in Colombia, Comparing Three Health Care Providers Nationwide

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • Costo- Efectividad Del Uso Profiláctico Del Factor Estimulante De Colonias De Granulocitos En Adultos Con Leucemia Linfoblástica Aguda en Colombia

    Dec 1, 2016, 00:00

  • Erratum

    Dec 1, 2016, 00:00

  • Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile

    Dec 1, 2016, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »